SNGX/ 04/28/2026 · 8:10 AM HyBryte Skin Cancer Drug Fails Key Test – Soligenix FLASH2 Trial Halted Soligenix stopped HyBryte CTCL trial early as it didn’t work well, though it was safe; company will review data and options.
